Try our corporate solution for free!
(212) 419-8286
hadley.ward@statista.com

Launch disruption on global pharmaceutical market due to coronavirus 2020-2025

It is estimated that the disruption in launches of new pharmaceutical products due to COVID-19 will have an aggregated negative impact of around 19 billion U.S. dollars until 2025. The first significant recovery is expected from 2026 on.

Impact of launch disruptions on the global pharmaceutical market due to COVID-19 from 2020 to 2025*

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

2020

Region

Worldwide

Survey time period

as of April 2020

Supplementary notes

* All values are projected and rounded.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Coronavirus: the pharma and medtech response"

Further Content: You might find this interesting as well

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.